Roflumilast
Roflumilast is a pharmaceutical drug with 79 clinical trials. Currently 6 active trials ongoing. Historical success rate of 88.9%.
Success Metrics
Based on 56 completed trials
Phase Distribution
Phase Distribution
16
Early Stage
21
Mid Stage
38
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.5%
56 of 64 finished
12.5%
8 ended early
6
trials recruiting
79
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Roflumilast and Desloratadine as Add-On Therapy in Patients With Rheumatoid Arthritis
Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)
Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)
Clinical Trials (79)
Effect of Roflumilast and Desloratadine as Add-On Therapy in Patients With Rheumatoid Arthritis
Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)
Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)
Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge
Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata
Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)
Roflumilast and TMS Motor Plasticity
Visualization of Topical Zoryve vs. Vehicle Using Line Field Optical Coherence Tomography in Healthy Skin
Study of Roflumilast in Combination With Standard Chemotherapy for High-risk Diffuse Large B-cell Lymphoma
Clinical Study Evaluating the Safety and Efficacy of Roflumilast in Type 2 Diabetic Patients With Diabetic Neuropathy
Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma
Long-term Observational Study of the Safety of Roflumilast
Efficacy of Roflumilast in the Treatment of Psoriasis
Efficacy of Roflumilast in Prevention of Peripheral Neuropathy
Roflumilast Versus Methotrexate in Psoriasis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 79